Management of Respiratory Viral Infections in Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies

Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections

(2014) D. P. Shah et al.   BLOOD

Executive Summary: 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

(2014) Lorry G. Rubin et al.   CLINICAL INFECTIOUS DISEASES

Parainfluenza Virus Lower Respiratory Tract Disease After Hematopoietic Cell Transplant: Viral Detection in the Lung Predicts Outcome

(2014) Sachiko Seo et al.   CLINICAL INFECTIOUS DISEASES

DAS181 treatment of hematopoietic stem cell transplant patients with parainfluenza virus lung disease requiring mechanical ventilation

(2014) S. Chalkias et al.   Transplant Infectious Disease

Outcome of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Hematopoietic Cell Transplant Recipients Receiving Aerosolized Ribavirin: Significance of Stem Cell Source and Oxygen Requirement

(2013) Sachiko Seo et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Respiratory Syncytial Virus Lower Respiratory Disease in Hematopoietic Cell Transplant Recipients: Viral RNA Detection in Blood, Antiviral Treatment, and Clinical Outcomes

(2013) Alpana Waghmare et al.   CLINICAL INFECTIOUS DISEASES

Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections

(2013) D. P. Shah et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Safety and Pharmacokinetics of Intravenous Zanamivir Treatment in Hospitalized Adults With Influenza: An Open-label, Multicenter, Single-Arm, Phase II Study

(2013) F. M. Marty et al.   JOURNAL OF INFECTIOUS DISEASES

Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Factors Determining Progression to Lower Respiratory Tract Disease

(2013) Yae-Jean Kim et al.   JOURNAL OF INFECTIOUS DISEASES

Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients

(2013) S. Gueller et al.   Transplant Infectious Disease

The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation

(2012) R. F. Chemaly et al.   BLOOD

Intravenous ribavirin for respiratory syncytial viral infections in pediatric hematopoietic SCT recipients

(2012) A Molinos-Quintana et al.   BONE MARROW TRANSPLANTATION

An Adaptive Randomized Trial of an Intermittent Dosing Schedule of Aerosolized Ribavirin in Patients With Cancer and Respiratory Syncytial Virus Infection

(2012) Roy F. Chemaly et al.   JOURNAL OF INFECTIOUS DISEASES

Characteristics and Outcomes of Pandemic 2009/H1N1 Versus Seasonal Influenza in Children With Cancer

(2012) Dimpy P. Shah et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Clinical potential of DAS181 for treatment of parainfluenza-3 infections in transplant recipients

(2012) B.B. Guzmán-Suarez et al.   Transplant Infectious Disease

Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients

(2011) S.-M. Choi et al.   BLOOD

Treatment of Parainfluenza 3 Infection With DAS181 in a Patient After Allogeneic Stem Cell Transplantation

(2011) Y.-B. Chen et al.   CLINICAL INFECTIOUS DISEASES

Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients

(2011) Christian Renaud et al.   CURRENT OPINION IN INFECTIOUS DISEASES

FilmArray, an Automated Nested Multiplex PCR System for Multi-Pathogen Detection: Development and Application to Respiratory Tract Infection

(2011) Mark A. Poritz et al.   PLoS One

RNA Interference Therapy in Lung Transplant Patients Infected with Respiratory Syncytial Virus

(2010) Martin R. Zamora et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Laninamivir Prodrug CS-8958, a Long-Acting Neuraminidase Inhibitor, Shows Superior Anti-Influenza Virus Activity after a Single Administration

(2010) S. Kubo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Antiviral Activity of Favipiravir (T-705) against Drug-Resistant Influenza and 2009 A(H1N1) Viruses

(2010) K. Sleeman et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Detection and Control of a Nosocomial Respiratory Syncytial Virus Outbreak in a Stem Cell Transplantation Unit: The Role of Palivizumab

(2010) Christelle Kassis et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Management of RSV infections in adult recipients of hematopoietic stem cell transplantation

(2010) J. N. Shah et al.   BLOOD

Intravenous Zanamivir for Patients with Pneumonitis due to Pandemic (H1N1) 2009 Influenza Virus

(2010) Georg Härter et al.   CLINICAL INFECTIOUS DISEASES

Long‐Acting Neuraminidase Inhibitor Laninamivir Octanoate versus Oseltamivir for Treatment of Influenza: A Double‐Blind, Randomized, Noninferiority Clinical Trial

(2010) Akira Watanabe et al.   CLINICAL INFECTIOUS DISEASES

Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181

(2010) Gallen B. Triana-Baltzer et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

A Recombinant Sialidase Fusion Protein Effectively Inhibits Human Parainfluenza Viral Infection In Vitro and In Vivo

(2010) Anne Moscona et al.   JOURNAL OF INFECTIOUS DISEASES

Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In Vitro

(2010) Jack T. Nguyen et al.   PLoS One

A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus

(2010) J. DeVincenzo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Efficacy of the New Neuraminidase Inhibitor CS-8958 against H5N1 Influenza Viruses

(2010) Maki Kiso et al.   PLoS Pathogens

Triple Combination of Oseltamivir, Amantadine, and Ribavirin Displays Synergistic Activity against Multiple Influenza Virus Strains In Vitro

(2009) J. T. Nguyen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

DAS181 Inhibits H5N1 Influenza Virus Infection of Human Lung Tissues

(2009) R. W. Y. Chan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective

(2009) Marcie Tomblyn et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation

(2009) J. T. Schiffer et al.   HAEMATOLOGICA

DAS181, a sialidase fusion protein, protects human airway epithelium against influenza virus infection: an in vitro pharmacodynamic analysis

(2009) Gallen B. Triana-Baltzer et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The Emergency Use Authorization of Peramivir for Treatment of 2009 H1N1 Influenza

(2009) Debra Birnkrant et al.   NEW ENGLAND JOURNAL OF MEDICINE

Emergence of Oseltamivir-Resistant Pandemic H1N1 Virus during Prophylaxis

(2009) Mariana Baz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Intravenous Zanamivir for Oseltamivir-Resistant 2009 H1N1 Influenza

(2009) Aditya H. Gaur et al.   NEW ENGLAND JOURNAL OF MEDICINE

Novel Pandemic Influenza A(H1N1) Viruses Are Potently Inhibited by DAS181, a Sialidase Fusion Protein

(2009) Gallen B. Triana-Baltzer et al.   PLoS One

Inhibition of Neuraminidase Inhibitor-Resistant Influenza Virus by DAS181, a Novel Sialidase Fusion Protein

(2009) Gallen B. Triana-Baltzer et al.   PLoS One

Influenza vaccination in hematopoietic SCT recipients

(2008) P Ljungman et al.   BONE MARROW TRANSPLANTATION

Palivizumab: where to from here?

(2008) Georgiana Georgescu et al.   EXPERT OPINION ON BIOLOGICAL THERAPY